Computed Tomography Characteristics of Lung Adenocarcinomas with Epidermal Growth Factor Receptor Mutation: A Propensity Score Matching Study
Overview
Authors
Affiliations
Objectives: We investigated the relationship between computed tomography (CT) characteristics and epidermal growth factor receptor (EGFR) mutations in a large Asian cohort who received surgical resection of invasive lung adenocarcinoma.
Materials And Methods: We retrospectively included 864 patients (524 with EGFR mutation and 340 with EGFR wild-type) who received surgical resections for invasive lung adenocarcinomas. After applying propensity score matching, 312 patients with mutated EGFR were matched with 312 patients with wild-type EGFR. CT characteristics, predominant histologic subtype, and CT measurement parameters (volume and estimated diameter of the total tumor and inner solid portion and ground-glass opacity [GGO] proportion) were compared within matched pairs.
Results: Tumors in the EGFR mutation group showed higher proportions of pure ground-glass nodules (4.1% vs 1.3%), GGO-predominant (23.7% vs 14.7%), and solid-predominant part-solid nodules (37.2% vs 31.7%) CT characteristics, whereas EGFR wild-type tumors predominantly presented as pure solid nodules (34.6% vs 52.2%, P < 0.0001). EGFR mutation tumors more frequently had a lepidic-predominant subtype than did EGFR wild-type tumors (20.2% and 11.9%; P < 0.0001), and showed a smaller whole tumor size and solid portion (P < 0.0001) with a higher GGO proportion (P < 0.0001). Tumors with exon 21 missense mutations showed the highest GGO proportion and the smallest inner solid portion size, followed by tumors harboring an exon 19 deletion, compared with EGFR wild-type tumors (posthoc P < 0.01).
Conclusion: Adenocarcinomas with EGFR mutations had a higher GGO proportion than those with wild-type EGFR after matching of clinical variables. Lesions with an exon 21 mutation had a higher GGO proportion than lesions with other mutations.
Correlation of CT features of lung adenocarcinoma with sex and age.
Yang Y, Gao Y, Lu F, Wang E, Liu H Sci Rep. 2024; 14(1):13414.
PMID: 38862598 PMC: 11167049. DOI: 10.1038/s41598-024-64335-7.
Herrera Ortiz A, Garland M, Almarie B Cureus. 2022; 14(5):e25446.
PMID: 35774697 PMC: 9238903. DOI: 10.7759/cureus.25446.
Xiang C, Ji C, Cai Y, Teng H, Wang Y, Zhao R Mod Pathol. 2022; 35(9):1181-1192.
PMID: 35641658 PMC: 9424111. DOI: 10.1038/s41379-022-01076-w.
Herrera Ortiz A, Camacho T, Vasquez A, Herazo V, Neira J, Yepes M Eur J Radiol Open. 2022; 9:100400.
PMID: 35198656 PMC: 8844749. DOI: 10.1016/j.ejro.2022.100400.
Ma J, Li M Transl Cancer Res. 2022; 10(9):4217-4231.
PMID: 35116717 PMC: 8797562. DOI: 10.21037/tcr-21-1037.